New treatment for chronic wounds now available on prescription

The haemoglobin spray Granulox has been added to the NHS Drug Tariff, establishing a new Haemoglobin category and is used in the treatment of chronic wounds. It will now be available on prescription across the UK. Currently more than 200,000 patients in the UK are living with non-healing wounds such as diabetic foot ulcers, venous leg ulcers, pressure ulcers and post-surgical wounds. Treating patients with chronic wounds costs the NHS between £2.3-3.1 billion a year in associated costs including nursing time, dressings, hospital admissions, pain relief and often unnecessary amputations. Granulox increases levels of oxygen at the wound bed, speeding